Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-1304-2024

DCA Systems HbA1c Reagent Kit

Publicado el 27 de marzo de 2024 · Inicio del retiro: 7 de febrero de 2024

Resumen

FDA registra el retiro Z-1304-2024 de dispositivos médicos de Clase II, publicado el 27 de marzo de 2024 e iniciado el 7 de febrero de 2024. Empresa responsable: Siemens Healthcare Diagnostics, Inc.; Estado: En curso; Cantidad reportada: 74,211 Kits (Expanded 2/28/24: additional 72,892 kits); Lote: Siemens Material Number: 10311134; UDI/DI: 00630414532806; Lot#: 9640093, 0645103, 0648103, 0649103, 0654103 . Expanded Lots (02/28/2024): 0637093, 0641093, 0642093, 0647103, 0653103, 0655103. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Siemens Healthcare Diagnostics, Inc.
Distribuidor
Worldwide distribution - US Nationwide and the country of Taiwan.
Lote
Siemens Material Number: 10311134; UDI/DI: 00630414532806; Lot#: 9640093, 0645103, 0648103, 0649103, 0654103 . Expanded Lots (02/28/2024): 0637093, 0641093, 0642093, 0647103, 0653103, 0655103;
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿DCA Systems HbA1c Reagent Kit fue retirado del mercado?

Sí. FDA publicó el retiro Z-1304-2024 el 27 de marzo de 2024. Peligro reportado: The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter